Trademark Overview
On Tuesday, June 3, 2025, a trademark application was filed for MAVNEQ with the United States Patent and Trademark Office. The USPTO has given the MAVNEQ trademark a serial number of 79427040. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, July 3, 2025. This trademark is owned by Mabwell (Shanghai) Bioscience Co., Ltd.. The MAVNEQ trademark is filed in the Pharmaceutical Products category with the following description:
Medicines for human purposes for cancer treatment; biological preparations for medical purposes for the treatment of cancer; pharmaceutical preparations for the treatment and prevention of cancer and malignant tumours; biochemical drugs, namely pharmaceutical preparations for treating malignant tumours; dietetic foods adapted for medical purposes; depuratives for the body; medicines for veterinary purposes, namely, veterinary vaccines and antibiotics; preparations for destroying vermin; medical dressings; dental abrasives